Intended for healthcare professionals


MEPs shun cancer advocacy group because of industry funding

BMJ 2008; 336 doi: (Published 01 May 2008) Cite this as: BMJ 2008;336:980
  1. Ned Stafford
  1. 1Hamburg

A group of members of the European parliament with a special interest in breast cancer has cut its ties with a breast cancer advocacy group, Europa Donna, because of the group’s acceptance of financial support from drug companies.

Karin Jöns, chairman of the European parliamentary group on breast cancer (EPGBC), issued a press release last week announcing the decision, saying that 86% of Europa Donna’s income of about €424 000 (£330 000; $660 000) in 2007 came from the industry.

“We at EPGBC reject further cooperation with Europa …

View Full Text

Log in

Log in through your institution


* For online subscription